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ABSTRACT 
Purpose: Peroxiredoxin-2 (PRDX-2) is an antioxidant and chaperone-like 
protein critical for cell function. This study examined whether the levels of 
lymphocyte PRDX-2 are altered over one month following ultra-endurance exercise. 
Methods: Nine middle-aged men undertook a single-stage, multi-day 233 km (145 
mile) ultra-endurance running race. Blood was collected immediately before (PRE), 
upon completion/retirement (POST), and following the race at DAY 1, DAY 7 and 
DAY 28. Lymphocyte lysates were examined for PRDX-2 by reducing SDS-PAGE 
and western blotting. In a sub-group of men who completed the race (n = 4) PRDX-
2 oligomeric state (indicative of redox status) was investigated. Results: Ultra-
endurance exercise caused significant changes in lymphocyte PRDX-2 (F (4,32) 
3.409, p=0.020, η2 =0.299): seven-days after the race, PRDX-2 levels in 
lymphocytes had fallen to 30% of pre-race values (p=0.013) and returned to near-
normal levels at DAY 28. Non-reducing gels demonstrated that dimeric PRDX-2 
(intracellular reduced PRDX-2 monomers) was increased in 3 of 4 race completers 
immediately post-race, indicative of an “antioxidant response”. Moreover, 
monomeric PRDX-2 was also increased immediately post-race in 2 of 4 race-
completing subjects, indicative of oxidative damage, which was not detectable by 
DAY 7. Conclusions: Lymphocyte PRDX-2 was decreased below normal levels 7 
 1
days after ultra-endurance exercise. Excessive accumulation of reactive oxygen 
species induced by ultra-endurance exercise may underlie depletion of lymphocyte 
PRDX-2 by triggering its turnover after oxidation. Low levels of lymphocyte PRDX-2 
could influence cell function and might, in part, explain reports of dysregulated 
immunity following ultra-endurance exercise. 
Keywords: Oxidative stress, reactive oxygen species, peroxiredoxins, running-
exercise human 
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INTRODUCTION 
Ultra-endurance exercise is associated with increased biomarkers of 
inflammation (e.g., the acute phase protein C reactive protein; CRP) and the 
production of reactive oxygen species (ROS) [1]. Although low levels of these highly 
reactive molecules are important for intracellular signaling, excess ROS can 
overwhelm antioxidant defences, causing oxidative damage in a variety of tissues, 
including lymphocytes [2]. The present study examined whether peroxiredoxin-2 
(PRDX-2), an antioxidant molecule important for immune function, was depleted in 
lymphocytes over the month following an ultra-endurance running race. 
One of the main functions of lymphocytes, the most predominant 
mononuclear cells in blood, is to provide immune surveillance by detecting and 
eliminating cells infected with viruses and bacteria, or cells that have undergone a 
malignant transformation. Following ultra-endurance exercise, lymphocytes exhibit 
increased oxidative damage as measured by protein oxidation and DNA damage 
[3,4]. Conceivably, exercise-induced oxidative damage in lymphocytes might alter 
aspects of immunity that rely on redox homeostasis. For example, lymphocyte 
activation, proliferation and cytotoxicity are impaired following depletion of the 
peroxide-quenching antioxidant molecule glutathione [5]. Moreover, low intracellular 
antioxidant levels and redox-sensitivity have been implicated in the reactivation of 
latent viruses [6] and there is substantial evidence that large volumes of exercise are 
associated with periods of illness [7]. Conversely, very low levels of PRDX-2 are 
associated with uncontrolled immune activation that might exacerbate inflammatory 
activity following exercise [8-10]. 
PRDX-2 is one of six isoforms of the peroxiredoxin family, which represent a 
group of multifunctional antioxidant enzymes, approximately 20-30 kDa in size [11]. 
All peroxiredoxin isoforms share the same antioxidant mechanism; the use of a 
catalytic cysteine residue to reduce peroxynitrite, hydrogen peroxide and 
hydroperoxides [12]. A major role for reduced peroxiredoxins is the control of redox-
dependent intracellular signaling, and therefore a variety of cell functions by 
regulating hydrogen peroxide levels [13]. Indeed, PRDX-2 is the most abundant 
antioxidant enzyme in the cytosol of lymphocytes, and its levels appear to be 
involved in the regulation of lymphocyte function [8,14]. Conversely, monocytes, a 
relatively minor proportion of mononuclear cells in blood, contain little or no PRDX-2 
[15]. 
PRDX-2 can exist in various redox states within a cell. Prior to reduction of 
peroxides, PRDX-2 is present as a reduced monomeric form, and upon reaction 
with molecules such as hydrogen peroxide, the catalytic cysteine residue becomes 
oxidized to form sulphenic acid in the first instance. This oxidized PRDX-2 monomer 
is only present transiently due to the rapid formation of a disulphide bond between 
the cysteine residue of a neighbouring PRDX-2 subunit, resulting in a dimer. In 
some circumstances PRDX-2 becomes over-oxidized to form sulphinic acid, 
inducing a structural transition that serves to induce cell cycle arrest [16]. Oxidation 
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of the catalytic cysteine residue to sulphinic and sulphonic acids, promotes 
disruption of alpha helices and the exposure of hydrophobic domains that drive the 
formation of stable decameric complexes of PRDX-2 [16]. In turn, decamers lack 
peroxidase activity, allow redox signaling and function as molecular chaperones to 
support the refolding of mildly-oxidized proteins [12]. 
We have shown previously that the levels of glutathione in whole blood are 
depleted for up to one month after ultra-endurance exercise [4]. Considering the 
majority of glutathione in whole blood is derived from erythrocytes, it remains largely 
unexplored whether ultra-endurance exercise depletes antioxidant defences in 
lymphocytes. In addition, since antioxidant molecules in lymphocytes are important 
for cell function and therefore immune surveillance, then depletion of these 
molecules might significantly affect immune function. The present study examined 
whether PRDX-2 level and oligomerisation is altered in lymphocytes over one 
month following ultra-endurance exercise. 
METHODS 
Ethical approval 
Informed consent was obtained in writing following ethical approval from the 
School of Sport and Exercise Sciences research ethics committee of the University 
of Birmingham (approved study number: 08/60). All procedures conformed to the 
standards set by the Declaration of Helsinki. 
Experimental design 
Nine healthy men (mean ± standard deviation; age 46.1 ± 5.3 years, body 
mass index 24.9 ± 2.3 kg.m-2, maximal oxygen consumption 56.3 ± 3.3 ml.kg-1.min-
1) took part in this study as previously described [4]. Participants undertook a single-
stage, multi-day 233 km (145 mile) running event. The race started at 06:00 on 
Saturday the 23rd of May 2009, and participants who completed the race, crossed 
the finish line between 21:15 on Sunday the 24th of May, and 01:50 on Monday the 
25th of May. Diet was not controlled for logistical reasons. Participants did not rest 
during the race, other than for very short periods (e.g., to urinate or change 
clothing) and none of the participants slept. The typical running strategy adopted by 
participants consisted of approximately 50-55 minutes of running, with 5-10 minutes 
of walking (allowing for recovery and nutritional intake), repeated in cycles until the 
race was completed. Due to exhaustion, the final hour of exercise was typically 
walking. Blood samples were collected immediately before the race (PRE) and as 
close to the time of exercise cessation for each participant as was logistically 
possible, irrespective of whether they retired early or completed the race (POST; 65 
± 64 minutes after). Additional blood samples were collected following the race at 
as close to 24 hours after exercise cessation as was logistically possible for each 
participant (DAY 1; mean 26 ± 4 hours) and seven and twenty-eight days later (DAY 
7 and DAY 28 respectively). Participants refrained from exercising for at least 7 
days after the race. 
 4
Sample preparation 
Plasma and peripheral blood mononuclear cells (PBMCs) were processed 
within 60 minutes of collection and frozen at −80°C as previously described [4]. 
PBMCs are hereafter referred to as lymphocytes as the results reported below 
reflect changes in lymphocyte, and not monocyte, PRDX-2 levels: monocytes 
represent a small proportion of PBMCs and contain little or no detectable PRDX-2 
[15]. Cell preparations were thawed and lysed using RIPA buffer (Thermo Scientific, 
UK) containing a protease inhibitor cocktail (Sigma Aldrich, Dorset UK). Total 
protein concentration was determined using the bicinchoninic acid method. 
Analytical procedures 
Plasma CRP was measured using an immunoturbidimetric assay based 
upon latex particle agglutination (Tina-quant® CRP latex high sensitivity assay, 
Indianapolis, USA) and measured on an automated clinical chemistry analyser 
(Roche Hitachi Cobas). 
Total PRDX-2 levels and monomeric, dimeric and decameric complexes of 
PRDX-2 were measured by reducing and non-reducing SDS-PAGE respectively, 
followed by western blotting. Proteins (10 µg) were loaded 1:1 in sample buffer (4% 
SDS, 20% glycerol, 0.004% bromophenol blue and 0.125 M Tris HCl, pH 6.8), with 
and without 10% 2-mercaptoethanol, onto 15 or 18 % polyacrylamide gels. 
Electrophoresis at 115V was performed for approximately 1.5 hours using a Mini-
PROTEAN® tetra-cell (Bio-Rad, Hemel Hempstead, UK) with electrophoresis buffer 
(25 mM Tris, pH 8.3, 192 mM glycine, and 0.2% w/v SDS). Separated proteins were 
transferred to Hybond-P® PVDF membrane (GE Healthcare, Amersham, UK) with 
transfer buffer (25 mM Tris, pH 8.3, 192 mM glycine, and 40% w/v methanol) for 2 
hours at 170mA. Membranes were blocked overnight at 4ºC with 3% BSA (Sigma 
Aldrich, Dorset, UK) in TBS, washed three times for 10 minutes in TTBS (0.05% 
Tween-20) and incubated with rabbit polyclonal anti-PRDX-2 antibody (1: 1000, 
Ab15572, AbCam, Cambridge, UK) or mouse monoclonal anti-actin antibody (1: 10 
000, Sigma Aldrich, Dorset, UK) for 2 hours at room temperature. PVDF 
membranes were washed three times for 10 minutes in TTBS (0.05% Tween-20). 
PRDX-2 blots were incubated with a peroxidase conjugated goat anti-rabbit 
antibody (1: 5000; A6154, Sigma Aldrich, Dorset, UK), and actin blots were 
incubated with a peroxidase-conjugated goat anti-mouse antibody (1: 25 000, 
Sigma Aldrich, Dorset, UK) for 2 hours at room temperature. Membranes were 
washed three times for 10 minutes in TTBS (0.05%) and visualized using ECL+ 
chemiluminescent detection system (GE Healthcare, Amersham, UK). Protein 
bands were scanned using a molecular imager GS-800 calibrated densitometer 
(Bio-Rad) and quantified using Quantity One™ software (Bio-Rad, Hemel 
Hempstead, UK). Densitometry values for each protein band were recorded and 
expressed as arbitrary units. 
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Data analysis 
Data were confirmed as having normal distribution using the Kolmogorov-
Smirnov test. Changes in PRDX-2 level were assessed using Analysis of Variance 
(ANOVA). Potential confounding factors (e.g., finishing status) were entered into 
ANOVAs as individual covariates and examined for significance (Analysis of co-
variance; ANCOVA). Effect sizes are reported as eta-squared (η2). Conventionally, 
η2 values of 0.01, 0.06, and 0.14 are considered small, medium and large effect 
sizes respectively. Post-hoc paired-samples t-tests identified differences relative to 
baseline. Significance was set at p < 0.05. Data are presented as means ± standard 
error of the mean (SEM) unless otherwise stated. Data were analysed using SPSS 
statistical package version 18.0 for Windows (SPSS Inc., USA). 
RESULTS 
Ultra-endurance race 
Four men completed the race (finishers). Table 1 shows that there were no 
physiological differences between the finishers (n = 4) and those who retired 
prematurely due to exhaustion (non-finishers; n = 5). As finishing status did not 
influence the results reported below as shown by analysis of covariance, all men 
were included in the main analyses (i.e., CRP, lymphocyte and monocyte 
responses, total PRDX-2 level). 
Ultra-endurance exercise induces an inflammatory response 
Compared to pre-race, plasma CRP was increased approximately 100-fold 
immediately post-race and remained at this level for 24 hours. Seven days after the 
race, plasma CRP remained approximately 8-fold higher than pre-race levels, 
returning to normal values within one month of the race (see Figure 1, main effects 
of time; F (4,32) 3.409, p < 0.001, η2 = 0.921). 
Lymphocyte and monocyte numbers before and after ultra-endurance exercise 
Table 2 shows lymphocyte and monocyte counts, and the ratio between 
these cells, in samples collected before and after ultra-endurance exercise. 
Immediately after the race, there was a trend for a fall in the number of lymphocytes 
(i.e., lymphocytopenia) and a significant increase in the number of monocytes (i.e., 
monocytosis). Subsequently, there was a trend for a fall in the 
lymphocyte/monocyte ratio immediately after exercise. In all other post-race 
samples (i.e., DAY 1, DAY 7 and DAY 28 post-race) lymphocyte and monocyte 
counts were comparable to pre-race levels. There were no significant differences in 
lymphocyte and monocyte counts in samples collected from finishers compared to 
non-finishers (time × finishing status interactions all; F (4,28) <1.49, p>0.05). 
Moreover, controlling statistically for minor fluctuations in the lymphocyte/monocyte 
ratio between samples did not influence the results reported below, as shown by 
analysis of covariance (data not shown). 
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Lymphocyte PRDX-2 is depleted below normal levels seven days after ultra-
endurance exercise 
Ultra-endurance exercise caused a significant alteration in the level of 
PRDX-2 in lymphocytes (see Figure 2, main effects of time; F (4,32) 3.409, p = 0.020, 
η2 = 0.299). Compared to baseline there was a 17% increase in PRDX-2 level 
immediately after the race (paired samples t-test; t (8) – 1.605, p = 0.147). Twenty-
four hours after exercise the level of PRDX-2 had fallen to 74% of pre-race values (t 
(8) = 0.854, p = 0.418). Seven-days after exercise PRDX-2 level fell to 30% of pre-
race values (paired samples t-test; t (8) 3.187, p = 0.013). Twenty eight days post-
race PRDX-2 returned to a similar level to that measured twenty-four hours after the 
race, which was not significantly different from baseline (76% of pre-race values; 
paired samples t-test; t (8) 1.037, p = 0.330). 
Lymphocyte PRDX-2 is over-oxidized after ultra-endurance exercise 
To investigate whether the changes in PRDX-2 level following ultra-
endurance exercise could be explained by PRDX-2 over-oxidation, samples from a 
sub-group of men (n = 4) were analysed. All men in this sub-group finished the race 
and their changes in PRDX-2 represented the group as a whole (n = 9). Samples 
were examined from the time points that showed the most pronounced changes in 
PRDX-2 (i.e., PRE, POST and DAY 7). Statistical analyses were not conducted on 
these data. 
As illustrated in Figure 3, under normal intracellular conditions, PRDX-2 can 
exist as a monomer, dimer or decamer, dependent on redox-state. Within cells, the 
monomeric form typically represents reduced PRDX-2. Oxidized PRDX-2 usually 
forms dimers. However, when ROS are in excess, the already oxidized PRDX-2 
becomes over-oxidized and may exist as a monomer or as a decamer [12]. Upon cell 
lysis, reduced monomeric PRDX-2 undergoes mild oxidation and therefore appears 
as dimers on non-reducing SDS-PAGE. Over-oxidized PRDX-2 usually resolves as 
a decamer. With excessive ROS production, PRDX-2 monomers are unable to 
dimerise due to over-oxidation, and therefore remain as monomers on non-reducing 
SDS-PAGE [14]. 
Figure 4A shows that two bands at approximately 250kDa and 50 kDa 
(indicative of decameric and dimeric PRDX-2 respectively) are present at baseline. 
For subject 1, 2 and 9, the intensity of the 50kDa band (indicative of reduced/mildly 
oxidized PRDX-2) increased immediately post-race. Moreover, a band at 
approximately 25kDa (indicative of monomeric over-oxidized PRDX-2) appeared 
immediately post-race in subjects 2 and 9. At seven days post-race, the band at 
25kDa was absent in all subjects, and there was a noticeable reduction in the 
intensity of the 50kDa band in subjects 1, 2, and 9. There was no noticeable change 
in intensity of the 50kDa and 25kDa bands post-race and seven days post-race 
compared to baseline in subject 8. 
Densitometry values of each band visible on non-reducing SDS-PAGE were 
expressed as a ratio of monomeric and decameric PRDX-2 (indicative of over-
oxidized) to dimeric PRDX-2 (indicative of reduced/mildly-oxidized) (Figure 4B). 
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This ratio increased immediately after and seven days post-race, indicative of 
oxidative stress. Further, when monomeric and decameric PRDX-2 and dimeric 
PRDX-2 were expressed as a proportion of all PRDX-2 oligomers, there was a clear 
increase in monomeric and decameric PRDX-2 (indicative of over-oxidized) and a 
concomitant decrease in dimeric PRDX-2 (indicative of reduced/mildly oxidized) 
immediately after and seven days post-race. These data suggest that ultra-
endurance exercise causes over-oxidation of PRDX-2 (Figure 4A). 
DISCUSSION 
This study demonstrates that lymphocyte PRDX-2 is depleted to less than 
one-third of normal levels (70% reduction) seven days after an ultra-endurance 
running event in nine middle-aged men. Further analyses in a sub-group of men 
who completed the race (n=4) indicated that in some individuals, PRDX-2 becomes 
over-oxidised after ultra-endurance exercise and is found predominantly in the 
decameric or monomeric forms. Whereas over-oxidized monomeric PRDX-2 
appears to be cleared within seven days, the over-oxidised decameric form seems 
to persist for at least seven days after ultra-endurance exercise. This is the first 
study to examine PRDX-2 levels and redox-state in lymphocytes following exercise. 
There was a large decrease in lymphocyte PRDX-2 levels seven days after 
the race. One possible explanation for this finding is that in response to excessive 
ROS production, perhaps mediated by post-exercise respiratory burst [10], PRDX-2 
becomes over-oxidized to the sulphinic or sulphonic forms which appear as 
monomers under non-reducing conditions. Although low concentrations of hydrogen 
peroxide transiently elevate PRDX-2 [17], high concentrations lower PRDX-2 mRNA 
and protein expression in lymphocytes and cause PRDX-2 over-oxidation [18,19]. 
Over-oxidized PRDX-2 can also form decamers and exhibit chaperone-like activity 
to protect cellular proteins from denaturation and promote refolding [20]. Eventually, 
over-oxidized PRDX-2 is degraded via the proteasome, the main intracellular 
pathway responsible for removal of oxidized proteins [21,22] and PRDX-2 levels 
return to normal or even below normal levels. Our results are consistent with the 
turnover of over-oxidized PRDX-2 in cells. In an analysis of non-reducing SDS-
PAGE in a sub-group of men who completed the race (n=4) and were therefore 
exposed to an equivalent level of exercise stress, we examined the redox status of 
PRDX-2 at the time points exhibiting the largest changes in total PRDX-2 (i.e., PRE, 
POST, DAY 7) using non-reducing SDS-PAGE. Our results suggest that over-
oxidized monomeric PRDX-2, which increased immediately post-race, was absent 
seven days later, possibly indicating clearance. 
A second explanation and possible function of the lower lymphocyte PRDX-2 
levels observed seven days after exercise might be related to homeostatic 
replacement of damaged and/or “senescent” T lymphocytes following exercise. For 
example, there are reports showing that a small number of lymphocytes (1-10%) 
can be damaged by exercise and become apoptotic [23]. It is unlikely that this small 
number of apoptotic cells could account for the changes in levels of PRDX-2 in total 
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lymphocytes directly, but PRDX-2 may be down-regulated in undamaged 
lymphocytes [8,9]. Such PRDX-2 down-regulation, which is implicated in lymphocyte 
proliferation, might function to replace “senescent” cells, such as terminally 
differentiated virus-specific T lymphocytes, which are characteristic of an ageing 
adaptive immune system [24]. Indeed, it has been proposed that exercise removes 
excess numbers of virus-specific lymphocytes, that are normally apoptosis-
resistant, to limit their accumulation during ageing and persistent infection [24]. The 
present results are consistent with this idea, where the down-regulation of PRDX-2 
may be an adaptive mechanism underlying the restorative proliferation of “healthy” 
cells following exercise. 
There is debate as to whether the health benefits of regular physical activity 
extend to extreme forms of exercise. Many studies have examined oxidative 
damage following ultra-endurance exercise [1], and while the majority of studies 
report increased biomarkers of oxidative damage in lymphocytes following exercise 
[3,4], others report little damage or no long lasting damage [25]. It has also been 
argued that the increased ROS production is beneficial, as it results in a 
characteristic “antioxidant response”, whereby the level of protective antioxidant 
enzymes is transiently elevated [26]. In the present study, there was a trend for 
increased lymphocyte PRDX-2 levels immediately after exercise. One explanation 
for this observation might be an acute antioxidant response to exercise-induced 
hydrogen peroxide accumulation [17], which for example, might be caused by 
superoxide release from mitochondria [27]. In support of this hypothesis, it has been 
shown experimentally that de novo synthesis of PRDX-2 occurs during, or in the 
hours following, an oxidative stress stimulus [18]. In addition, the increase in 
hydrogen peroxide level might exceed the capacity for removal due to over-
oxidation of PRDX-2, as shown for subjects 2 and 9 during the course of exercise 
(Figure 3A). An alternative explanation for the elevated PRDX-2 levels observed in 
this study might be due to non-specific, exercise induced T lymphocyte activation, 
since stimulating the T cell receptor results in hydrogen peroxide-mediated 
signaling and a subsequent increase in PRDX-2 levels [8]. Indeed, the increased 
expression of lymphocyte cell surface proteins associated with activation during 
exercise, including CD25 (the IL-2 receptor), CD69 and HLA-DR, suggests that 
exercise can directly activate T lymphocytes in peripheral blood [28]. 
The lower PRDX-2 levels in lymphocytes following ultra-endurance exercise 
in the present study, might be an attractive mechanism to examine in future studies 
attempting to understand the reports of dysregulated immunity (i.e., inflammatory 
activity and upper respiratory tract infections; URTI) following extreme exercise [7,29]. 
While glutathione depletion is associated with viral reactivation and impaired 
lymphocyte function [6], lower than normal levels of PRDX-2 are associated with the 
reverse: uncontrolled and inappropriate immune activation [8]. PRDX-2 is a critical 
regulator of cell-mediated immunity and animals lacking the PRDX-2 gene show 
uncontrolled expansion of CD8+ T lymphocytes in models of chronic infection, which 
results in lethal immunopathology [8]. Therefore, low levels of PRDX-2 in CD8+ T 
lymphocytes might exaggerate inflammatory responses in the days following 
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exercise, considering these cells are potent producers of IFN-γ, TNF-α and IL-6 
[30,31]. In the present study, CRP, an acute phase reactant released from the liver in 
response to IL-6, was approximately 100-fold higher than normal for at least 24 
hours after ultra-endurance exercise. Values close to 100 mg/L, as reported in the 
present study, are typically associated with major bacterial infections. Seven days 
after ultra-endurance exercise, CRP was approximately 8-fold higher than normal 
levels, which returned to pre-race values within one month of the race. Considering 
CRP has a half life of 4-6 hours, the present results show that ultra-endurance 
exercise results a temporary period (i.e., 7 days) of inflammation that is akin to 
inflammatory disorders. Interestingly, individuals with larger-than-normal 
inflammatory responses to environmental stressors are more likely to exhibit 
symptoms of URTI, than individuals with normal inflammatory responses [32]. 
It should be considered that in the present study PRDX-2 was measured in 
PBMCs, a heterogenous population of cells consisting mostly of lymphocytes but 
also some monocytes. While the majority of PRDX-2 would have been derived from 
lymphocytes as monocytes contain little or no PRDX-2 [15], the results could in 
principle, be influenced by the proportion of each cell type in the samples. For 
example, in the present study, samples collected immediately post-race contained 
fewer lymphocytes and more monocytes compared to pre-race samples. Despite 
normalising for total protein assayed, compared to pre-race, a larger proportion of 
the protein was derived from monocytes post-race. Thus, it might be expected for 
the level of PRDX-2 to fall. In the present study however, the opposite was true: 
there was a trend for an increase in PRDX-2 immediately post-race, presumably 
evidence of an “antioxidant response”. Moreover, the main finding that lymphocyte 
PRDX-2 is depleted below normal levels seven days after ultra-endurance exercise, 
is derived from comparing two blood samples collected at rest (i.e., PRE vs. DAY 
7), in which the proportion of lymphocytes and monocytes were comparable. 
The present study describes for the first time the kinetics of PRDX-2 
oligomerisation and expression level in lymphocytes following ultra-endurance 
exercise. Although PRDX-2 has not been examined previously following this type of 
exercise, increased concentrations of the antioxidant molecule thioredoxin-1 has 
been reported in plasma immediately after ultra-endurance exercise [33]. In the 
context of the present results, an increase in thioredoxin-1 might be part of the 
antioxidant response to exercise, which serves to recycle mildly oxidized PRDX-2 
following exercise-induced hydrogen peroxide production. In the context of chronic 
exercise training, PRDX-2 levels have been shown to elevated in erythrocytes [34] 
but not in muscle [35] after three months of moderate intensity cycling. 
Taken together with existing literature, the present results indicate that 
exercise causes time-dependent changes in the level, redox-state and likely 
turnover of PRDX-2, which may be a consequence of excess ROS production in 
lymphocytes. The immunological consequences of these observations remain to be 
elucidated. 
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Table Legends 
Table 1 
Characteristics of finishers and non-finishers (mean ± standard deviation). 
 Finishers (n=4) a, Non-finishers (n =5) b  
Age (years) 43 ± 3 49 ± 6 p >.05 
Body Mass Index (Kg.m2) 23.7 ± 1.3 25.8 ± 2.7 p >.05 
Body Fat (%) 14.0 ± 1.3 14.2 ± 3.3 p >.05 
LTPAc (MET.min.week-1) 2837 ± 911 4116 ± 931 p >.05 
VO2max (ml.kg-1.min-1) 58.6 ± 3.1 54.5 ± 2.2 p >.05 
Max Heart Rate (bpm) 174 ± 4 176 ± 5 p >.05 
Running distance (km) 233.4 ± 0.0 126.7 ± 29.7 p <.01 
Running duration (hh:mm) 41:40 ± 2:13 20:44 ± 7:15 p <.01 
Running speed (km/h) 5.6 ± 0.7 6.6 ± 0.7 p >.05 
a independent samples t-test between finishers and non-finishers 
b Finishing status did not confound the changes in lymphocyte peroxiredoxin-2 level 
as determined by analysis of covariance. 
c Leisure Time Physical Activity, as assessed by the international physical activity 
questionnaire (IPAQ) 
Table 2 
Lymphocyte and monocyte numbers 
Cells x109 PRE POST DAY 1 DAY 7 DAY 28 
Lymphocytes 2.56 ± 0.82 2.03 ± 0.73 2.27 ± 0.50 2.08 ± 0.44 2.24 ± 0.54 
Monocytes 0.34 ± 0.16 0.68 ± 0.36* 0.41 ± 0.27 0.30 ± 0.09 0.36 ± 0.21 
Lymph/Mono 9.22 ± 6.00 3.92 ± 2.74 7.84 ± 4.92 7.49 ± 2.84 9.53 ± 7.29 
*p < 0.05 paired samples t-test compared to PRE 
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Figure Ledgends 
Figure 1 
Plasma CRP increases in response to ultra-endurance running (n=9). *** p<0.001 
compared to PRE. 
 
Figure 2 
Total PRDX-2 levels in response to ultra-endurance running. A) Bars represent 
total PRDX-2 levels in lymphocyte cell lysates (n=9). Error bars indicate mean ± 
SEM. PRDX-2 was depleted below pre-race levels seven days after ultra-
endurance exercise. B) Representative western blots of lymphocyte cell lysates 
under reducing conditions. 
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Figure 3 
PRDX-2 oligomeric states. A) Cellular PRDX-2 oligomers: reduced PRDX-2 
monomers can be oxidized to sulphenic acid. This mildly oxidized monomer can be 
attacked by a neighbouring cysteine on a PRDX-2 subunit to form an inter-
disulphide bond resulting in an oxidized dimer, or over-oxidized to sulphinic or 
sulphonic acid, which in turn can form over-oxidized decamers. B) PRDX-2 
oligomers under non-reducing conditions: upon cell lysis, reduced monomeric 
PRDX-2 undergoes mild oxidation to sulphenic acid and resolves as dimers 
(50kDa), whereas over-oxidized PRDX-2 can either exist as a decamer (250kDa) 
and also as a monomer (25kDa). 
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Figure 4 
PRDX-2 redox state in response to ultra-endurance running (n = 4; finishers 
only). A) Western blots for decameric, dimeric and monomeric forms of PRDX-2 in 
lymphocyte cell lysates under non-reducing conditons (n=4; all men finished the 
race). PRE, POST and DAY 7 time points were selected to examine the most 
pronounced changes in PRDX-2 level. Over-oxidation of PRDX-2 can be seen 
immediately post-race as shown by a 25kDa band that is prominent in subjects 2 
and 9, which is absent seven days later. B) PRDX-2 level represented as a ratio of 
over-oxidized to reduced/mildly oxidized PRDX-2. C) Over-oxidized and 
reduced/mildly oxidized PRDX-2 expressed as a percentage of all PRDX-2 
oligomers present under non-reducing conditions. 
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